What are you looking for today?

Myers, SM (2012) Hit validation of ERK5 inhibitors: Expectations and challenges. In: ACS 243rd National Meeting and Exposition, 25-29 Mar 2012, San Diego, USA.

Document

  • [thumbnail of 243rd-National-ACS-Meeting-mediabstractf2012.pdf]
    243rd-National-ACS-Meeting-mediabstractf2012.pdf

Abstract

Abstract

Extracellular signal-regulated kinase 5 (ERK5) plays a key role in the transduction of extracellular signals to intracellular effectors. Activation of the ERK5 signalling pathway is associated with cell survival and proliferation, and thus ERK5 over-expression has implications in carcinogenesis. Inhibiting ERK5 is therefore an effective approach for anti-cancer therapy. Following a high throughput screening campaign, three chemical series (1 -3) were selected for validation. The syntheses and biological evaluation of novel benzo[d]thiazoles (1), 4-aminopyrimidine-5-carbonitriles (2) and 3 cyanopyridines (3) will be discussed.

Item Type: Conference or Workshop Item (Poster)
Depositing User: Stephanie Myers
URI: https://sure.sunderland.ac.uk/id/eprint/17743

Further Details

More Information

Depositing User

Identifiers

Item ID
17743

Users with ORCIDS

Catalogue record

Date Deposited
26 Jun 2024 10:50
Last Modified
04 Jun 2025 16:06

Contributors

Author
SM Myers
Author
Stephanie Myers

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year